Skip to content
OpenCapital
Get started

NTHI NTHI Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.6×-0.1×
Pfizer logo
PfizerPFE
2.5×+0.2×
Merck & Co. logo
Merck & Co.MRK
4.5×+1.0×
Nuvation Bio logo
Nuvation BioNUVB
10.4×-44.0×
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
210.5×-3,896×

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K—
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K—
Free cash flow-$5.2M—

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%

Profitability

See full
Operating margin-46,870.7%—
Net margin-51,613.3%—
FCF margin-26,083.2%—

Returns & leverage

See full
Return on equity338.1%—
Debt / equity-0.1×—
Current ratio0.1×-0.3×